MediSapiens is excited to launch the evolution of its Genomics Software Suite (GSS), version 1.2. GSS is a scalable, adaptable SaaS solution for data-driven operations. GSS allows our partners to use and apply large cohorts of omics data with a fast return of results. It offers great flexibility in managing omics data sources, combining these…
Genomic medicine may facilitate predictive, preventive and personalized (or precision) health care, improve cost efficiency of medical care and promote efficacy, speed and success rates of drug development. The utilization of the world’s increasing genomic and clinical data resources holds the promise of driving new breakthroughs in drug development, disease prevention, diagnostics and patient care.…
MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others. To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials…
BCB Medical and MediSapiens are thrilled to announce their cooperation in the field of data standardization. Both BCB and MediSapiens are participants in the EHDEN, European Health Data & Evidence Network. In the EHDEN, BCB Medical is a data partner, providing data for conversion to the OMOP Common Data Model, while MediSapiens is currently the…
If you have followed the MediSapiens social media pages (Linkedin, Twitter, Facebook) over the past year or so, you are likely to have seen the terms EHDEN and OMOP and that MediSapiens has been heavily involved with these as the first EHDEN-certified OMOP service provider in the Nordics. But what are EHDEN and OMOP? To…